Hydroxychloroquine for Thrombosis Prevention and Antiphospholipid Antibody Reduction in Primary Antiphospholipid Syndrome
Condition: Antiphospholipid Syndrome Intervention: Drug: Hydroxychloroquine Sponsor: National and Kapodistrian University of Athens Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2019 Category: Research Source Type: clinical trials